Form 8-K - Current report:
SEC Accession No. 0001493152-24-040780
Filing Date
2024-10-10
Accepted
2024-10-10 17:30:24
Documents
39
Period of Report
2024-10-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38215
2 ex99-1.htm EX-99.1 23823
3 ex99-2_001.jpg GRAPHIC 875092
4 ex99-2_002.jpg GRAPHIC 1463774
5 ex99-2_003.jpg GRAPHIC 723207
6 ex99-2_004.jpg GRAPHIC 1095407
7 ex99-2_005.jpg GRAPHIC 610154
8 ex99-2_006.jpg GRAPHIC 1068103
9 ex99-2_007.jpg GRAPHIC 943717
10 ex99-2_008.jpg GRAPHIC 979977
11 ex99-2_009.jpg GRAPHIC 815383
12 ex99-2_010.jpg GRAPHIC 760999
13 ex99-2_011.jpg GRAPHIC 889937
14 ex99-2_012.jpg GRAPHIC 856343
15 ex99-2_013.jpg GRAPHIC 841774
16 ex99-2_014.jpg GRAPHIC 826855
17 ex99-2_015.jpg GRAPHIC 1042342
18 ex99-2_016.jpg GRAPHIC 921677
19 ex99-2_017.jpg GRAPHIC 1130131
20 ex99-2_018.jpg GRAPHIC 869501
21 ex99-2_019.jpg GRAPHIC 1058302
22 ex99-2_020.jpg GRAPHIC 904095
23 ex99-2_021.jpg GRAPHIC 833508
24 ex99-2_022.jpg GRAPHIC 1248706
25 ex99-2_023.jpg GRAPHIC 1262070
26 ex99-2_024.jpg GRAPHIC 966539
27 ex99-2_025.jpg GRAPHIC 882132
  Complete submission text file 0001493152-24-040780.txt   32892204

Data Files

Seq Description Document Type Size
28 XBRL SCHEMA FILE kapa-20241009.xsd EX-101.SCH 3027
29 XBRL LABEL FILE kapa-20241009_lab.xml EX-101.LAB 34240
30 XBRL PRESENTATION FILE kapa-20241009_pre.xml EX-101.PRE 24173
41 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3799
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42275 | Film No.: 241365953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)